niclosamide has been researched along with EBV Infections in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L | 1 |
| Yang, M | 1 |
| Yuan, Y | 1 |
| Li, X | 1 |
| Kuang, E | 1 |
1 other study available for niclosamide and EBV Infections
| Article | Year |
|---|---|
Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
Topics: Cell Line, Tumor; DNA Replication; Epithelial Cells; Epstein-Barr Virus Infections; Herpesvirus 4, H | 2017 |